rplC T460C Identified as a Dominant Mutation in Linezolid-Resistant Mycobacterium tuberculosis Strains
Beckert P, Hillemann D, Kohl T, Kalinowski J, Richter E, Niemann S, Feuerriegel S (2012)
Antimicrobial Agents and Chemotherapy 56(5): 2743-2745.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Beckert, Patrick;
Hillemann, Doris;
Kohl, ThomasUniBi;
Kalinowski, JörnUniBi;
Richter, Elvira;
Niemann, Stefan;
Feuerriegel, Silke
Einrichtung
Abstract / Bemerkung
The ribosomal L3 protein was identified as a novel target in linezolid (LZD)-resistant Mycobacterium tuberculosis strains. Next-generation sequencing confirmed rplC T460C as the sole mutation in an LZD-resistant M. tuberculosis H37Rv strain selected in vitro. Sequencing analysis revealed the rplC T460C mutation in eight further LZD-resistant isolates (three in vitro-selected mutants and five patient isolates, including isolates from three different patients that developed LZD resistance during treatment) but in none of the susceptible control strains (n = 84).
Erscheinungsjahr
2012
Zeitschriftentitel
Antimicrobial Agents and Chemotherapy
Band
56
Ausgabe
5
Seite(n)
2743-2745
ISSN
0066-4804
eISSN
1098-6596
Page URI
https://pub.uni-bielefeld.de/record/2501701
Zitieren
Beckert P, Hillemann D, Kohl T, et al. rplC T460C Identified as a Dominant Mutation in Linezolid-Resistant Mycobacterium tuberculosis Strains. Antimicrobial Agents and Chemotherapy. 2012;56(5):2743-2745.
Beckert, P., Hillemann, D., Kohl, T., Kalinowski, J., Richter, E., Niemann, S., & Feuerriegel, S. (2012). rplC T460C Identified as a Dominant Mutation in Linezolid-Resistant Mycobacterium tuberculosis Strains. Antimicrobial Agents and Chemotherapy, 56(5), 2743-2745. doi:10.1128/AAC.06227-11
Beckert, Patrick, Hillemann, Doris, Kohl, Thomas, Kalinowski, Jörn, Richter, Elvira, Niemann, Stefan, and Feuerriegel, Silke. 2012. “rplC T460C Identified as a Dominant Mutation in Linezolid-Resistant Mycobacterium tuberculosis Strains”. Antimicrobial Agents and Chemotherapy 56 (5): 2743-2745.
Beckert, P., Hillemann, D., Kohl, T., Kalinowski, J., Richter, E., Niemann, S., and Feuerriegel, S. (2012). rplC T460C Identified as a Dominant Mutation in Linezolid-Resistant Mycobacterium tuberculosis Strains. Antimicrobial Agents and Chemotherapy 56, 2743-2745.
Beckert, P., et al., 2012. rplC T460C Identified as a Dominant Mutation in Linezolid-Resistant Mycobacterium tuberculosis Strains. Antimicrobial Agents and Chemotherapy, 56(5), p 2743-2745.
P. Beckert, et al., “rplC T460C Identified as a Dominant Mutation in Linezolid-Resistant Mycobacterium tuberculosis Strains”, Antimicrobial Agents and Chemotherapy, vol. 56, 2012, pp. 2743-2745.
Beckert, P., Hillemann, D., Kohl, T., Kalinowski, J., Richter, E., Niemann, S., Feuerriegel, S.: rplC T460C Identified as a Dominant Mutation in Linezolid-Resistant Mycobacterium tuberculosis Strains. Antimicrobial Agents and Chemotherapy. 56, 2743-2745 (2012).
Beckert, Patrick, Hillemann, Doris, Kohl, Thomas, Kalinowski, Jörn, Richter, Elvira, Niemann, Stefan, and Feuerriegel, Silke. “rplC T460C Identified as a Dominant Mutation in Linezolid-Resistant Mycobacterium tuberculosis Strains”. Antimicrobial Agents and Chemotherapy 56.5 (2012): 2743-2745.
31 Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
Deciphering drug resistance in Mycobacterium tuberculosis using whole-genome sequencing: progress, promise, and challenges.
Cohen KA, Manson AL, Desjardins CA, Abeel T, Earl AM., Genome Med 11(1), 2019
PMID: 31345251
Cohen KA, Manson AL, Desjardins CA, Abeel T, Earl AM., Genome Med 11(1), 2019
PMID: 31345251
Linezolid resistance in patients with drug-resistant TB and treatment failure in South Africa.
Wasserman S, Louw G, Ramangoaela L, Barber G, Hayes C, Omar SV, Maartens G, Barry C, Song T, Meintjes G., J Antimicrob Chemother 74(8), 2019
PMID: 31081017
Wasserman S, Louw G, Ramangoaela L, Barber G, Hayes C, Omar SV, Maartens G, Barry C, Song T, Meintjes G., J Antimicrob Chemother 74(8), 2019
PMID: 31081017
Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains.
Hameed HMA, Islam MM, Chhotaray C, Wang C, Liu Y, Tan Y, Li X, Tan S, Delorme V, Yew WW, Liu J, Zhang T., Front Cell Infect Microbiol 8(), 2018
PMID: 29755957
Hameed HMA, Islam MM, Chhotaray C, Wang C, Liu Y, Tan Y, Li X, Tan S, Delorme V, Yew WW, Liu J, Zhang T., Front Cell Infect Microbiol 8(), 2018
PMID: 29755957
Use of whole genome sequencing in surveillance of drug resistant tuberculosis.
McNerney R, Zignol M, Clark TG., Expert Rev Anti Infect Ther 16(5), 2018
PMID: 29718745
McNerney R, Zignol M, Clark TG., Expert Rev Anti Infect Ther 16(5), 2018
PMID: 29718745
Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis.
Lange C, Alghamdi WA, Al-Shaer MH, Brighenti S, Diacon AH, DiNardo AR, Grobbel HP, Gröschel MI, von Groote-Bidlingmaier F, Hauptmann M, Heyckendorf J, Köhler N, Kohl TA, Merker M, Niemann S, Peloquin CA, Reimann M, Schaible UE, Schaub D, Schleusener V, Thye T, Schön T., J Intern Med (), 2018
PMID: 29806961
Lange C, Alghamdi WA, Al-Shaer MH, Brighenti S, Diacon AH, DiNardo AR, Grobbel HP, Gröschel MI, von Groote-Bidlingmaier F, Hauptmann M, Heyckendorf J, Köhler N, Kohl TA, Merker M, Niemann S, Peloquin CA, Reimann M, Schaible UE, Schaub D, Schleusener V, Thye T, Schön T., J Intern Med (), 2018
PMID: 29806961
Comparison of In Vitro Activity and MIC Distributions between the Novel Oxazolidinone Delpazolid and Linezolid against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis in China.
Zong Z, Jing W, Shi J, Wen S, Zhang T, Huo F, Shang Y, Liang Q, Huang H, Pang Y., Antimicrob Agents Chemother 62(8), 2018
PMID: 29844043
Zong Z, Jing W, Shi J, Wen S, Zhang T, Huo F, Shang Y, Liang Q, Huang H, Pang Y., Antimicrob Agents Chemother 62(8), 2018
PMID: 29844043
Drug resistance mechanisms and drug susceptibility testing for tuberculosis.
Miotto P, Zhang Y, Cirillo DM, Yam WC., Respirology 23(12), 2018
PMID: 30189463
Miotto P, Zhang Y, Cirillo DM, Yam WC., Respirology 23(12), 2018
PMID: 30189463
Collated data of mutation frequencies and associated genetic variants of bedaquiline, clofazimine and linezolid resistance in Mycobacterium tuberculosis.
Ismail N, Omar SV, Ismail NA, Peters RPH., Data Brief 20(), 2018
PMID: 30306102
Ismail N, Omar SV, Ismail NA, Peters RPH., Data Brief 20(), 2018
PMID: 30306102
Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea.
Yang JS, Kim KJ, Choi H, Lee SH., Ann Lab Med 38(6), 2018
PMID: 30027700
Yang JS, Kim KJ, Choi H, Lee SH., Ann Lab Med 38(6), 2018
PMID: 30027700
Drug resistance mechanisms and novel drug targets for tuberculosis therapy.
Islam MM, Hameed HMA, Mugweru J, Chhotaray C, Wang C, Tan Y, Liu J, Li X, Tan S, Ojima I, Yew WW, Nuermberger E, Lamichhane G, Zhang T., J Genet Genomics 44(1), 2017
PMID: 28117224
Islam MM, Hameed HMA, Mugweru J, Chhotaray C, Wang C, Tan Y, Liu J, Li X, Tan S, Ojima I, Yew WW, Nuermberger E, Lamichhane G, Zhang T., J Genet Genomics 44(1), 2017
PMID: 28117224
Linezolid: a promising option in the treatment of Gram-positives.
Zahedi Bialvaei A, Rahbar M, Yousefi M, Asgharzadeh M, Samadi Kafil H., J Antimicrob Chemother 72(2), 2017
PMID: 27999068
Zahedi Bialvaei A, Rahbar M, Yousefi M, Asgharzadeh M, Samadi Kafil H., J Antimicrob Chemother 72(2), 2017
PMID: 27999068
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.
Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, Furin J, Nardell EA, London L, Lessem E, Theron G, van Helden P, Niemann S, Merker M, Dowdy D, Van Rie A, Siu GK, Pasipanodya JG, Rodrigues C, Clark TG, Sirgel FA, Esmail A, Lin HH, Atre SR, Schaaf HS, Chang KC, Lange C, Nahid P, Udwadia ZF, Horsburgh CR, Churchyard GJ, Menzies D, Hesseling AC, Nuermberger E, McIlleron H, Fennelly KP, Goemaere E, Jaramillo E, Low M, Jara CM, Padayatchi N, Warren RM., Lancet Respir Med (), 2017
PMID: 28344011
Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, Furin J, Nardell EA, London L, Lessem E, Theron G, van Helden P, Niemann S, Merker M, Dowdy D, Van Rie A, Siu GK, Pasipanodya JG, Rodrigues C, Clark TG, Sirgel FA, Esmail A, Lin HH, Atre SR, Schaaf HS, Chang KC, Lange C, Nahid P, Udwadia ZF, Horsburgh CR, Churchyard GJ, Menzies D, Hesseling AC, Nuermberger E, McIlleron H, Fennelly KP, Goemaere E, Jaramillo E, Low M, Jara CM, Padayatchi N, Warren RM., Lancet Respir Med (), 2017
PMID: 28344011
New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria.
Nasiri MJ, Haeili M, Ghazi M, Goudarzi H, Pormohammad A, Imani Fooladi AA, Feizabadi MM., Front Microbiol 8(), 2017
PMID: 28487675
Nasiri MJ, Haeili M, Ghazi M, Goudarzi H, Pormohammad A, Imani Fooladi AA, Feizabadi MM., Front Microbiol 8(), 2017
PMID: 28487675
Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives.
Gygli SM, Borrell S, Trauner A, Gagneux S., FEMS Microbiol Rev 41(3), 2017
PMID: 28369307
Gygli SM, Borrell S, Trauner A, Gagneux S., FEMS Microbiol Rev 41(3), 2017
PMID: 28369307
Molecular detection methods of resistance to antituberculosis drugs in Mycobacterium tuberculosis.
Brossier F, Sougakoff W, French National Reference Center for Mycobacteria(b)., Med Mal Infect 47(5), 2017
PMID: 28629614
Brossier F, Sougakoff W, French National Reference Center for Mycobacteria(b)., Med Mal Infect 47(5), 2017
PMID: 28629614
Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region.
Zimenkov DV, Nosova EY, Kulagina EV, Antonova OV, Arslanbaeva LR, Isakova AI, Krylova LY, Peretokina IV, Makarova MV, Safonova SG, Borisov SE, Gryadunov DA., J Antimicrob Chemother 72(7), 2017
PMID: 28387862
Zimenkov DV, Nosova EY, Kulagina EV, Antonova OV, Arslanbaeva LR, Isakova AI, Krylova LY, Peretokina IV, Makarova MV, Safonova SG, Borisov SE, Gryadunov DA., J Antimicrob Chemother 72(7), 2017
PMID: 28387862
The Complete Structure of the Mycobacterium smegmatis 70S Ribosome.
Hentschel J, Burnside C, Mignot I, Leibundgut M, Boehringer D, Ban N., Cell Rep 20(1), 2017
PMID: 28683309
Hentschel J, Burnside C, Mignot I, Leibundgut M, Boehringer D, Ban N., Cell Rep 20(1), 2017
PMID: 28683309
Combined Effect of the Cfr Methyltransferase and Ribosomal Protein L3 Mutations on Resistance to Ribosome-Targeting Antibiotics.
Pakula KK, Hansen LH, Vester B., Antimicrob Agents Chemother 61(9), 2017
PMID: 28630201
Pakula KK, Hansen LH, Vester B., Antimicrob Agents Chemother 61(9), 2017
PMID: 28630201
In Vitro Isolation and Characterization of Oxazolidinone-Resistant Mycobacterium tuberculosis.
McNeil MB, Dennison DD, Shelton CD, Parish T., Antimicrob Agents Chemother 61(10), 2017
PMID: 28760892
McNeil MB, Dennison DD, Shelton CD, Parish T., Antimicrob Agents Chemother 61(10), 2017
PMID: 28760892
Mycobacterium tuberculosis Mutations Associated with Reduced Susceptibility to Linezolid.
Zhang S, Chen J, Cui P, Shi W, Shi X, Niu H, Chan D, Yew WW, Zhang W, Zhang Y., Antimicrob Agents Chemother 60(4), 2016
PMID: 26810645
Zhang S, Chen J, Cui P, Shi W, Shi X, Niu H, Chan D, Yew WW, Zhang W, Zhang Y., Antimicrob Agents Chemother 60(4), 2016
PMID: 26810645
Role of the Cys154Arg Substitution in Ribosomal Protein L3 in Oxazolidinone Resistance in Mycobacterium tuberculosis.
Makafe GG, Cao Y, Tan Y, Julius M, Liu Z, Wang C, Njire MM, Cai X, Liu T, Wang B, Pang W, Tan S, Zhang B, Yew WW, Lamichhane G, Guo J, Zhang T., Antimicrob Agents Chemother 60(5), 2016
PMID: 26953211
Makafe GG, Cao Y, Tan Y, Julius M, Liu Z, Wang C, Njire MM, Cai X, Liu T, Wang B, Pang W, Tan S, Zhang B, Yew WW, Lamichhane G, Guo J, Zhang T., Antimicrob Agents Chemother 60(5), 2016
PMID: 26953211
Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index.
Wasserman S, Meintjes G, Maartens G., Expert Rev Anti Infect Ther 14(10), 2016
PMID: 27532292
Wasserman S, Meintjes G, Maartens G., Expert Rev Anti Infect Ther 14(10), 2016
PMID: 27532292
Bioinformatics tools and databases for whole genome sequence analysis of Mycobacterium tuberculosis.
Faksri K, Tan JH, Chaiprasert A, Teo YY, Ong RT., Infect Genet Evol 45(), 2016
PMID: 27637931
Faksri K, Tan JH, Chaiprasert A, Teo YY, Ong RT., Infect Genet Evol 45(), 2016
PMID: 27637931
Mutations in the bacterial ribosomal protein l3 and their association with antibiotic resistance.
Klitgaard RN, Ntokou E, Nørgaard K, Biltoft D, Hansen LH, Trædholm NM, Kongsted J, Vester B., Antimicrob Agents Chemother 59(6), 2015
PMID: 25845869
Klitgaard RN, Ntokou E, Nørgaard K, Biltoft D, Hansen LH, Trædholm NM, Kongsted J, Vester B., Antimicrob Agents Chemother 59(6), 2015
PMID: 25845869
Bactericidal activity and mechanism of action of AZD5847, a novel oxazolidinone for treatment of tuberculosis.
Balasubramanian V, Solapure S, Iyer H, Ghosh A, Sharma S, Kaur P, Deepthi R, Subbulakshmi V, Ramya V, Ramachandran V, Balganesh M, Wright L, Melnick D, Butler SL, Sambandamurthy VK., Antimicrob Agents Chemother 58(1), 2014
PMID: 24189255
Balasubramanian V, Solapure S, Iyer H, Ghosh A, Sharma S, Kaur P, Deepthi R, Subbulakshmi V, Ramya V, Ramachandran V, Balganesh M, Wright L, Melnick D, Butler SL, Sambandamurthy VK., Antimicrob Agents Chemother 58(1), 2014
PMID: 24189255
Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
Zhang Z, Pang Y, Wang Y, Liu C, Zhao Y., Int J Antimicrob Agents 43(3), 2014
PMID: 24439458
Zhang Z, Pang Y, Wang Y, Liu C, Zhao Y., Int J Antimicrob Agents 43(3), 2014
PMID: 24439458
In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis.
Zhang M, Sala C, Dhar N, Vocat A, Sambandamurthy VK, Sharma S, Marriner G, Balasubramanian V, Cole ST., Antimicrob Agents Chemother 58(6), 2014
PMID: 24663022
Zhang M, Sala C, Dhar N, Vocat A, Sambandamurthy VK, Sharma S, Marriner G, Balasubramanian V, Cole ST., Antimicrob Agents Chemother 58(6), 2014
PMID: 24663022
Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.
Mendes RE, Deshpande LM, Jones RN., Drug Resist Updat 17(1-2), 2014
PMID: 24880801
Mendes RE, Deshpande LM, Jones RN., Drug Resist Updat 17(1-2), 2014
PMID: 24880801
Drug Resistance Mechanisms in Mycobacterium tuberculosis.
Palomino JC, Martin A., Antibiotics (Basel) 3(3), 2014
PMID: 27025748
Palomino JC, Martin A., Antibiotics (Basel) 3(3), 2014
PMID: 27025748
From multidrug-resistant to extensively drug-resistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition.
Perdigão J, Macedo R, Silva C, Machado D, Couto I, Viveiros M, Jordao L, Portugal I., J Antimicrob Chemother 68(1), 2013
PMID: 23054995
Perdigão J, Macedo R, Silva C, Machado D, Couto I, Viveiros M, Jordao L, Portugal I., J Antimicrob Chemother 68(1), 2013
PMID: 23054995
Linezolid for treatment of chronic extensively drug-resistant tuberculosis.
Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Jeon HS, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee JK, Lee D, Kim CT, Dartois V, Park SK, Cho SN, Barry CE., N Engl J Med 367(16), 2012
PMID: 23075177
Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Jeon HS, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee JK, Lee D, Kim CT, Dartois V, Park SK, Cho SN, Barry CE., N Engl J Med 367(16), 2012
PMID: 23075177
13 References
Daten bereitgestellt von Europe PubMed Central.
Oxazolidinones: activity, mode of action, and mechanism of resistance.
Bozdogan B, Appelbaum PC., Int. J. Antimicrob. Agents 23(2), 2004
PMID: 15013035
Bozdogan B, Appelbaum PC., Int. J. Antimicrob. Agents 23(2), 2004
PMID: 15013035
In vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants.
Hillemann D, Rusch-Gerdes S, Richter E., Antimicrob. Agents Chemother. 52(2), 2007
PMID: 18070973
Hillemann D, Rusch-Gerdes S, Richter E., Antimicrob. Agents Chemother. 52(2), 2007
PMID: 18070973
Resistance to linezolid in a porcine Clostridium perfringens strain carrying a mutation in the rplD gene encoding the ribosomal protein L4.
Holzel CS, Harms KS, Schwaiger K, Bauer J., Antimicrob. Agents Chemother. 54(3), 2010
PMID: 20065060
Holzel CS, Harms KS, Schwaiger K, Bauer J., Antimicrob. Agents Chemother. 54(3), 2010
PMID: 20065060
Extensively drug-resistant tuberculosis: current challenges and threats.
Jain A, Mondal R., FEMS Immunol. Med. Microbiol. 53(2), 2008
PMID: 18479439
Jain A, Mondal R., FEMS Immunol. Med. Microbiol. 53(2), 2008
PMID: 18479439
The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria.
Leach KL, Swaney SM, Colca JR, McDonald WG, Blinn JR, Thomasco LM, Gadwood RC, Shinabarger D, Xiong L, Mankin AS., Mol. Cell 26(3), 2007
PMID: 17499045
Leach KL, Swaney SM, Colca JR, McDonald WG, Blinn JR, Thomasco LM, Gadwood RC, Shinabarger D, Xiong L, Mankin AS., Mol. Cell 26(3), 2007
PMID: 17499045
Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin.
Locke JB, Hilgers M, Shaw KJ., Antimicrob. Agents Chemother. 53(12), 2009
PMID: 19805557
Locke JB, Hilgers M, Shaw KJ., Antimicrob. Agents Chemother. 53(12), 2009
PMID: 19805557
Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).
Locke JB, Hilgers M, Shaw KJ., Antimicrob. Agents Chemother. 53(12), 2009
PMID: 19752277
Locke JB, Hilgers M, Shaw KJ., Antimicrob. Agents Chemother. 53(12), 2009
PMID: 19752277
Strategies against multidrug-resistant tuberculosis.
Loddenkemper R, Sagebiel D, Brendel A., Eur Respir J Suppl 36(), 2002
PMID: 12168749
Loddenkemper R, Sagebiel D, Brendel A., Eur Respir J Suppl 36(), 2002
PMID: 12168749
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis.
Migliori GB, Eker B, Richardson MD, Sotgiu G, Zellweger JP, Skrahina A, Ortmann J, Girardi E, Hoffmann H, Besozzi G, Bevilacqua N, Kirsten D, Centis R, Lange C; TBNET Study Group, Hurevich H, Skrahin A, Muetterlein R, Schaberg T, Eberhardt R, Flick H, de Roux A, Hamm M, Hang H, Hannemann P, Hillemann D, Kretz B, Laumanns C, Paulick A, Pletz MW, Rau M, Schaudt C, Matteelli A, Spanevello A, Toungoussova O, D'Ambrosio L, De Lorenzo S, Troupioti P, De Iaco G, Gualano A, De Mori P, Lauria FN, Ferrara G, Cirillo D, Janssens JP., Eur. Respir. J. 34(2), 2009
PMID: 19282348
Migliori GB, Eker B, Richardson MD, Sotgiu G, Zellweger JP, Skrahina A, Ortmann J, Girardi E, Hoffmann H, Besozzi G, Bevilacqua N, Kirsten D, Centis R, Lange C; TBNET Study Group, Hurevich H, Skrahin A, Muetterlein R, Schaberg T, Eberhardt R, Flick H, de Roux A, Hamm M, Hang H, Hannemann P, Hillemann D, Kretz B, Laumanns C, Paulick A, Pletz MW, Rau M, Schaudt C, Matteelli A, Spanevello A, Toungoussova O, D'Ambrosio L, De Lorenzo S, Troupioti P, De Iaco G, Gualano A, De Mori P, Lauria FN, Ferrara G, Cirillo D, Janssens JP., Eur. Respir. J. 34(2), 2009
PMID: 19282348
Current and novel antibiotics against resistant Gram-positive bacteria.
Perez F, Salata RA, Bonomo RA., Infect Drug Resist 1(), 2008
PMID: 21694878
Perez F, Salata RA, Bonomo RA., Infect Drug Resist 1(), 2008
PMID: 21694878
First linezolid-resistant clinical isolates of Mycobacterium tuberculosis.
Richter E, Rusch-Gerdes S, Hillemann D., Antimicrob. Agents Chemother. 51(4), 2007
PMID: 17242139
Richter E, Rusch-Gerdes S, Hillemann D., Antimicrob. Agents Chemother. 51(4), 2007
PMID: 17242139
Linezolid in the treatment of multidrug-resistant tuberculosis.
Schecter GF, Scott C, True L, Raftery A, Flood J, Mase S., Clin. Infect. Dis. 50(1), 2010
PMID: 19947856
Schecter GF, Scott C, True L, Raftery A, Flood J, Mase S., Clin. Infect. Dis. 50(1), 2010
PMID: 19947856
Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus.
Wolter N, Smith AM, Farrell DJ, Schaffner W, Moore M, Whitney CG, Jorgensen JH, Klugman KP., Antimicrob. Agents Chemother. 49(8), 2005
PMID: 16048983
Wolter N, Smith AM, Farrell DJ, Schaffner W, Moore M, Whitney CG, Jorgensen JH, Klugman KP., Antimicrob. Agents Chemother. 49(8), 2005
PMID: 16048983
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 22371899
PubMed | Europe PMC
Suchen in
Google Scholar